UNSPSC 85534059: Bypass inferior vena cava to inferior mesenteric vein with autologous arterial tissue, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass inferior vena cava to inferior mesenteric vein with autologous arterial tissue, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06104A6

UNSPSC 85534059 Bypass inferior vena cava to inferior mesenteric vein with autologous arterial tissue, percutaneous endoscopic approach is a Commodity code that does not match the work state and local governments are actually soliciting under it. Recent posted opportunities show no vascular surgery procedures or medical device procurement. Instead, the code has been applied to unrelated solicitations for independent medical evaluation services, surgical benefit plan administration, occupational medical surveillance, youth detention healthcare, pharmacy benefit management, and temporary health professional staffing — none of which involve bypass surgery or the specialized vascular intervention the code nominally describes. This mismatch suggests either a data entry error in the code assignment or a systematic misclassification in how state and local procurement offices are tagging these opportunities.

The recent opportunities themselves span diverse issuing bodies—the City of Phoenix Retirement Office, City of Long Beach Human Resources, Washington State Department of Transportation, Harris County Juvenile Probation Department, Collier County Board of Commissioners, and Santa Clara County Health System—and cover medical administration, occupational health, benefits management, and staffing procurement rather than surgical services. The geographic spread includes Arizona, California, Washington, Texas, and Florida. Without genuine state and local procurement activity aligned to the code's actual scope, the code presents no clear business development opportunity for firms pursuing vascular surgery products or services through public-sector channels.